Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilep
about
Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies.Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?Effect of a Gluten-Free Diet on Cortical Excitability in Adults with Celiac Disease.All- Trans-Retinoic Acid Augments the Histopathological Outcome of Neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice.A Potential Role for Felbamate in TSC- and NF1-Related Epilepsy: A Case Report and Review of the Literature.Stapled peptides: providing the best of both worlds in drug development.Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii.A Systems Medicine Approach Reveals Disordered Immune System and Lipid Metabolism in Multiple Sclerosis Patients.Hydrolysis by catalytic IgGs of microRNA specific for patients with schizophrenia.Schizophrenia among patients with systemic lupus erythematosus: population-based cross-sectional study.Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.Autoimmune limbic encephalitis: A manifestation of systemic lupus erythematosus in the central nervous system.Neuropsychiatric SLE: from animal model to human.Psycho-rheumatic Integration in Systemic Lupus Erythematosus: An Insight into Antibodies Causing Neuropsychiatric Changes
P2860
Q26738436-050B1378-6A3A-4665-B021-21BE8532AFEBQ33871737-960A983E-2BF8-4675-9BB1-5D2B2060F5B4Q35656494-7D1ED8F0-F2F5-431B-A202-0EC47C373D12Q38406678-0F3ADDF6-6FDC-4A50-A1E5-A6AADFB3A6BEQ38636941-40135800-F4DA-4DFB-A32C-850C1CDB3EA7Q38818907-002DBC78-D429-40BA-A93A-B61199596B1EQ38819747-B410DBF5-99F4-4939-A92F-CC5D43553D4AQ38954648-E11B320B-79EB-45C6-A609-06D41819BC0DQ40758347-3CAE4C90-A929-4C90-B8B0-AB90DD3C000EQ47342256-A9BB2B43-BADA-4601-B072-186930851CDDQ47554999-73DFECBA-C808-4DE8-BD1C-701A227622C6Q48036190-9FFD3F36-5255-4F1D-A6DF-F5395F4F2559Q48621584-7D0F77C5-35A3-4C05-8A50-3C7D57C6CEE9Q50042787-CD82B906-2CF0-4667-9290-3D477843763DQ51065096-38659B75-149A-4403-8851-87D73088345BQ57495680-3FE6A068-B86B-4F88-A9EF-27A172C352E6
P2860
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilep
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Glutamate receptor antibodies ...... f patients with either: epilep
@en
type
label
Glutamate receptor antibodies ...... f patients with either: epilep
@en
prefLabel
Glutamate receptor antibodies ...... f patients with either: epilep
@en
P2860
P1476
Glutamate receptor antibodies ...... f patients with either: epilep
@en
P2093
Mia Levite
P2860
P2888
P304
P356
10.1007/S00702-014-1193-3
P577
2014-08-01T00:00:00Z